Security key
75901B107
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 51,538,736
- Total 13F shares
- 42,526,783
- Share change
- +1,444,048
- Total reported value
- $354,201,107
- Put/Call ratio
- 68%
- Price per share
- $8.38
- Number of holders
- 176
- Value change
- +$5,353,040
- Number of buys
- 88
- Number of sells
- 84
Report period
Q1 2026
Institutions
176
Top holders
10
RGNX full security history
Previous quarter: Q4 2025
REGENXBIO Inc. SEC filings
REGENXBIO Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75901B107
Recent filing periods:
Top shareholders of RGNX - REGENXBIO Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
13D/G
|
Company |
9.9%
from 13D/G
|
4,368,804
|
$62,910,778 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
13D/G
|
Company |
7.4%
from 13D/G
|
3,553,502
|
$51,170,429 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.3%
from 13D/G
|
5,756,811
|
$82,898,078 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
5.3%
from 13D/G
|
2,286,736
|
$32,928,998 | — | 31 Dec 2025 | |
| BlackRock Portfolio Management LLC |
13D/G
|
— |
4.1%
|
2,085,619
|
$30,032,914 | -$15,091,042 | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.5%
|
3,374,140
|
$48,587,616 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
3.9%
|
2,014,788
|
$29,012,955 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
3.5%
|
1,785,437
|
$25,710,293 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.6%
|
1,361,962
|
$19,612,253 | — | 31 Dec 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
2.3%
|
1,200,000
|
$17,280,000 | — | 31 Dec 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.3%
|
1,160,380
|
$16,709,472 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
1,145,206
|
$16,495,225 | — | 31 Dec 2025 | |
| 22NW, LP |
13F
|
Company |
1.8%
|
923,679
|
$13,300,978 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.8%
|
903,851
|
$13,014,235 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.3%
|
658,510
|
$9,482,544 | — | 31 Dec 2025 | |
| Pale Fire Capital SE |
13F
|
Company |
0.97%
|
499,526
|
$7,193,174 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.86%
|
442,690
|
$6,374,736 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.76%
|
391,461
|
$5,637,038 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.73%
|
375,399
|
$5,404,000 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.73%
|
373,689
|
$5,381,121 | — | 31 Dec 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.65%
|
335,046
|
$4,824,676 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.65%
|
333,086
|
$4,796,438 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.58%
|
300,609
|
$4,328,769 | — | 31 Dec 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.58%
|
299,915
|
$4,318,000 | — | 31 Dec 2025 | |
| Voss Capital, LP |
13F
|
Company |
0.57%
|
295,000
|
$4,248,000 | — | 31 Dec 2025 | |
| GSK plc |
13F
|
Company |
0.53%
|
271,456
|
$3,908,966 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.52%
|
266,095
|
$3,831,764 | — | 31 Dec 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.49%
|
250,698
|
$3,610,051 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.48%
|
247,367
|
$3,562,085 | — | 31 Dec 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.43%
|
222,715
|
$3,207,096 | — | 31 Dec 2025 | |
| ArchPoint Investors |
13F
|
Company |
0.43%
|
222,278
|
$3,200,803 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.42%
|
214,666
|
$3,091,190 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.4%
|
206,689
|
$2,976,322 | — | 31 Dec 2025 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.39%
|
200,000
|
$2,880,000 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.38%
|
196,521
|
$2,829,903 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.37%
|
192,582
|
$2,773,181 | — | 31 Dec 2025 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.36%
|
186,667
|
$2,688,005 | — | 31 Dec 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.35%
|
178,025
|
$2,563,560 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.32%
|
164,421
|
$2,367,662 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.31%
|
157,903
|
$2,273,803 | — | 31 Dec 2025 | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13F
|
Company |
0.29%
|
149,000
|
$2,146,000 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.28%
|
145,594
|
$2,096,557 | — | 31 Dec 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.28%
|
144,848
|
$2,085,811 | — | 31 Dec 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.27%
|
140,000
|
$2,016,000 | — | 31 Dec 2025 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
0.26%
|
133,556
|
$1,923,206 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.25%
|
129,941
|
$1,871,150 | — | 31 Dec 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.23%
|
119,038
|
$1,714,147 | — | 31 Dec 2025 | |
| Propel Bio Management, LLC |
13F
|
Company |
0.23%
|
116,896
|
$1,683,302 | — | 31 Dec 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.22%
|
114,988
|
$1,655,827 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.22%
|
113,134
|
$1,629,129 | — | 31 Dec 2025 |
Institutional Holders of REGENXBIO Inc. - COMMON STOCK (RGNX) as of Q1 2026
As of 31 Mar 2026,
REGENXBIO Inc. - COMMON STOCK (RGNX) was held by
176 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,526,783 shares.
The largest 10 holders included
BlackRock, Inc., Redmile Group, LLC, JPMORGAN CHASE & CO, STATE STREET CORP, MORGAN STANLEY, VANGUARD CAPITAL MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, Integral Health Asset Management, LLC, Qube Research & Technologies Ltd, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
176
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
173
Q1 2026 holders
176
Holder diff
3
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.